Unknown

Dataset Information

0

TRIM28 attenuates Bortezomib sensitivity of hepatocellular carcinoma cells through enhanced proteasome expression.

ABSTRACT:

SUBMITTER: Zhang J 

PROVIDER: S-EPMC8782260 | biostudies-literature | 2022 Jan

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

TRIM28 attenuates Bortezomib sensitivity of hepatocellular carcinoma cells through enhanced proteasome expression.

Zhang Jianchao J   Fan Xiaokai X   Liao Lijuan L   Zhu Yan Y   Wan Xiaochun X   Rao Hai H   Chen Liang L  

Clinical and translational medicine 20220101 1

Similar Datasets

Unknown HMOX1 Attenuates the Sensitivity of Hepatocellular Carcinoma Cells to Sorafenib via Modulating the Expression of ABC Transporters.
| S-EPMC9253870 | biostudies-literature
Unknown Targeting MAGE-C1/CT7 expression increases cell sensitivity to the proteasome inhibitor bortezomib in multiple myeloma cell lines.
| S-EPMC3218015 | biostudies-literature
Unknown Ubiquitin-proteasome system-based signature to predict the prognosis and drug sensitivity of hepatocellular carcinoma.
| S-EPMC10166894 | biostudies-literature
Unknown Bortezomib sensitivity is tissue dependent and high expression of the 20S proteasome precludes good response in malignant pleural mesothelioma.
| S-EPMC6765394 | biostudies-literature
Unknown NEDD4L binds the proteasome and promotes autophagy and bortezomib sensitivity in multiple myeloma.
| S-EPMC8891287 | biostudies-literature
Unknown TGF-β Induces Degradation of PTHrP Through Ubiquitin-Proteasome System in Hepatocellular Carcinoma.
| S-EPMC4439935 | biostudies-literature
Unknown Upregulation of Protein Synthesis and Proteasome Degradation Confers Sensitivity to Proteasome Inhibitor Bortezomib in Myc-Atypical Teratoid/Rhabdoid Tumors.
| S-EPMC7140067 | biostudies-literature
Unknown The proteasome inhibitor bortezomib attenuates renal fibrosis in mice via the suppression of TGF-β1.
| S-EPMC5638992 | biostudies-literature
Unknown TRIM55 restricts the progression of hepatocellular carcinoma through ubiquitin-proteasome-mediated degradation of NF90.
| S-EPMC11487063 | biostudies-literature
Unknown RNF8 depletion attenuates hepatocellular carcinoma progression by inhibiting epithelial-mesenchymal transition and enhancing drug sensitivity.
| S-EPMC10195149 | biostudies-literature